Increased valinomycin production in mutants of Streptomyces sp. M10 defective in bafilomycin biosynthesis and branched-chain α-keto acid dehydrogenase complex expression

Journal of Industrial Microbiology & Biotechnology
Dong Wan LeeBeom Seok Kim

Abstract

Streptomyces sp. M10 is a valinomycin-producing bacterial strain that shows potent bioactivity against Botrytis blight of cucumber plants. During studies to increase the yield of valinomycin (a cyclododecadepsipeptide) in strain M10, additional antifungal metabolites, including bafilomycin derivatives (macrolide antibiotics), were identified. To examine the effect of bafilomycin biosynthesis on valinomycin production, the bafilomycin biosynthetic gene cluster was cloned from the genome of strain M10, as were two branched-chain α-keto acid dehydrogenase (BCDH) gene clusters related to precursor supply for bafilomycin biosynthesis. A null mutant (M10bafm) of one bafilomycin biosynthetic gene (bafV) failed to produce bafilomycin, but resulted in a 1.2- to 1.5-fold increase in the amount of valinomycin produced. In another null mutant (M10bkdFm) of a gene encoding a subunit of the BCDH complex (bkdF), bafilomycin production was completely abolished and valinomycin production increased fourfold relative to that in the wild-type M10 strain. The higher valinomycin yield was likely the result of redistribution of the metabolic flux from bafilomycin to valinomycin biosynthesis, because the two antibiotics share a common precursor, 2-ket...Continue Reading

References

Mar 1, 1976·Bacteriological Reviews·L K MasseyR S Conrad
Jan 1, 1991·Folia Microbiologica·Z VanĕkE Curdová
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E J BowmanK Altendorf
Jan 1, 1985·Molecular & General Genetics : MGG·K F ChaterI Tobek
Nov 1, 1985·The Journal of Antibiotics·J H WiltonJ C French
Apr 18, 1985·Nature·D A HopwoodS Omura
Feb 1, 1985·The Journal of Antibiotics·M A GoetzG Albers-Schonberg
Mar 1, 1997·Journal of Bacteriology·K T MadhusudhanJ R Sokatch
Feb 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bertolt GustKeith F Chater
Apr 5, 2003·Molecular Microbiology·Arie B BrinkmanJohn van der Oost
Feb 1, 1960·Canadian Journal of Microbiology·J C MACDONALD
Oct 19, 2004·Annual Review of Microbiology·Robert Finking, Mohamed A Marahiel
Jan 11, 2005·The Journal of Antibiotics·Tim Schuhmann, Stephanie Grond
Jan 11, 2005·Applied and Environmental Microbiology·Veronika ElisákováStéphane Delaunay
May 10, 2007·Pest Management Science·Leonard G Copping, Stephen O Duke
Sep 17, 2009·Journal of Industrial Microbiology & Biotechnology·SangJoon MoYeo Joon Yoon
Jan 22, 2010·Applied Microbiology and Biotechnology·Yihua ChenBen Shen
Jan 31, 2013·Chembiochem : a European Journal of Chemical Biology·Wei ZhangShengying Li
Jun 20, 2013·Journal of Industrial Microbiology & Biotechnology·Di HuangXiaoqiang Jia
Aug 28, 2013·Applied Biochemistry and Biotechnology·Eduardo José CrevelinLuiz Alberto Beraldo Moraes

❮ Previous
Next ❯

Citations

Feb 8, 2018·Journal of Industrial Microbiology & Biotechnology·Shuai LuoYong-Quan Li
Jan 19, 2021·Microbial Biotechnology·Zhiyong WuGuiyang Shi
Aug 7, 2021·Antibiotics·Balasubramanian Cibichakravarthy, Polapass Arul Jose

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.